<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03092050</url>
  </required_header>
  <id_info>
    <org_study_id>MIT001</org_study_id>
    <secondary_id>R21AG051970</secondary_id>
    <nct_id>NCT03092050</nct_id>
  </id_info>
  <brief_title>Group Therapy for Depressed Dementia Caregivers</brief_title>
  <official_title>Group Therapy for Depressed Caregivers of Alzheimer's Disorder and Related Dementias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Depression in family caregivers of relatives with Alzheimer's Disorder and related dementias
      is a serious public health problem. This is a randomized, controlled, single-blind pilot
      clinical trial of 50 depressed caregivers, to determine the efficacy and mechanisms of group
      therapy for depressed dementia caregivers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 arm randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Blinded to study hypotheses.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Depression symptoms</measure>
    <time_frame>approximately 4 weeks post initial group session</time_frame>
    <description>Self reported depression symptoms (Quick Inventory of Depression Symptoms)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression symptoms - moderate term</measure>
    <time_frame>approximately 3 months post initial group session</time_frame>
    <description>Self reported depression symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression symptoms - clinician rated</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>Hamilton Depression Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver burden</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>Caregiver Burden Scale self rated questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety symptoms</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>State Trait Anxiety Inventory - Trait</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindfulness</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>Five Factor Mindfulness Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive and Negative Affect</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>Positive and Negative Affect Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Well-Being</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>Mental Health Continuum Short Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>Perceived Stress Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resilience</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>Connors Davidson Resilience Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Connectedness to Nature</measure>
    <time_frame>approximately 4 weeks post initial group session and approximately 3 months post initial group session</time_frame>
    <description>Connectedness to Nature Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Facilitated Discussion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Weekly facilitated discussion for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Guided Imagery and mindfulness</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Weekly guided imagery and mindfulness for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Guided Imagery and Mindfulness</intervention_name>
    <description>This is a behavioral intervention using guided imagery and mindfulness techniques.</description>
    <arm_group_label>Guided Imagery and mindfulness</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Facilitated Discussion</intervention_name>
    <description>This is a behavioral intervention that involves discussion and group support.</description>
    <arm_group_label>Facilitated Discussion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Endorse clinically relevant baseline depressive symptoms Primary caregiver for a relative
        with dementia

        Exclusion Criteria:

        Age &lt; 45 Meditation / guided imagery practice more than twice per week Ideas of harming
        relative with dementia Current violence towards relative with dementia Adult Protective
        Services report on file Primary psychiatric disorder other than unipolar major depression
        Cognitive impairment on the part of the caregiver (Mini Mental State Examination score less
        than 24) Unstable medical illness Planned surgery Active drug or alcohol abuse Inability to
        understand written and oral English.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felipe Jain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 10, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Felipe A Jain</investigator_full_name>
    <investigator_title>Psychiatrist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

